Uniform Long-Term Gene Expression using Adeno-Associated Virus (AAV) by Ex Vivo Recirculation in Rat-Cardiac Isografts

Abstract

Background: Gene therapy in cardiovascular disease promises to be of great impact. The ideal vector for the therapeutic gene transfection remains to be determined. The aim of the present study was to investigate the efficacy of gene transfer using adeno-associated virus vectors carrying the lacZ-reporter gene (AAV-lacZ) in a previously described coronary recirculation model. Methods: Beating Lewis rat hearts perfused with oxygenated Krebs-Henseleit solution were harvested, after which an atrial septal defect (ASD) was created. All vessels were tied, and AAV-lacZ was injected into the aortic root. The solution was recirculated through the ASD to the left side of the heart and pumped back to the coronary arteries by the left ventricle. Incubation was allowed for 20 min at 15° C, and the hearts were subsequently transplanted heterotopically in syngeneic rats. Three increasing doses (109, 1010, 1011 e. u.) of AAV-lacZ virus vectors were used to study the rate of gene transfer. All hearts were harvested after 7 - 60 days and evaluated histologically for expression of the lacZ-gene. Results: Dose-dependent gene transfer was observed. Even after 60 days, there was no obvious decline in gene expression. Conclusion: Adeno-associated virus vectors offer effective and uniform gene transfer in the myocardium after transcoronary injection and recirculation. Due to the lack of immune response previously described, no decrease in gene expression can be observed up to 60 days after injection.

Gene therapy - cardiovascular gene transfer - Adeno-associated virus vectors

References

• 1 Sinnaeve P, Varenne O, Collen D, Janssens S. Gene therapy in the cardiovascular system: an update.  Cardiovascular Research. 1999;  44 (3) 498-506
• 2 Kessler P D, Podsakoff G M, Chen X. et al . Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.  Proc Natl Acad Sci USA. 1996;  93 (24) 14082-14087
• 3 Svensson E C, Marshall D J, Woodard K. et al . Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.  Circulation. 1999;  99 (2) 201-205
• 4 Logeart D, Hatem S N, Heimburger M, Le R oux, Michel J B, Mercadier J J. How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?.  Hum Gene Ther. 2001;  12 (13) 1601-1610
• 5 Asfour B, Byrne B J, Baba H A. et al . Effective gene transfer in the rat myocardium via adenovirus vectors using a coronary recirculation model.  Thorac Cardiovasc Surg. 1999;  47 (5) 311-316
• 6 Ono K, Lindsey E S. Improved technique of heart transplantation in rats.  J Thorac Cardiovasc Surg. 1969;  57 (2) 225-229
• 7 Acsadi G, Jiao S S, Jani A. et al . Direct gene transfer and expression into rat heart in vivo.  New Biol. 1991;  3 (1) 71-81
• 8 Christ M, Lusky M, Stoeckel F. et al . Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.  Immunol Lett. 1997;  57 (1-3) 19-25
• 9 Cotmore S F, Tattersall P. The autonomously replicating parvoviruses of vertebrates.  Adv Virus Res. 1987;  33 91-174
• 10 Ostrove J M, Leonard J, Weck K E, Rabson A B, Gendelman H E. Activation of the immunodeficiency virus by herpes simplex virus tye 1.  J Virol. 1987;  61 3726-3732
• 11 Samulski R J, Chang L S, Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication.  J Virol. 1987;  61 (10) 3096-3101
• 12 Samulski R J, Chang L S, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.  J Virol. 1989;  63 (9) 3822-3828
• 13 Kaplitt M G, Xiao X, Samulski R J. et al . Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector.  Ann Thorac Surg. 1996;  62 (6) 1669-1676
• 14 Lynch C M, Hara P S, Leonard J C, Williams J K, Dean R H, Geary R L. Adeno-associated virus vectors for vascular gene delivery.  Circ Res. 1997;  80 (4) 497-505
• 15 Berns K I, Giraud C. Biology of adeno-associated virus.  Curr Top Microbiol Immunol. 1996;  218 1-23
• 16 Xiao X, Li J, Samulski R J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. .  J Virol. 1996;  70 8098-8108
• 17 Gojo S, Niwaya K, Taniguchi S, Nishizaki K, Kitamura S. Gene transfer into the donor heart during cold preservation for heart transplantation.  Ann Thorac Surg. 1998;  65 (3) 647-652
• 18 Pellegrini C, T O B, Yap J, Jeppsson A, Tazelaar H D, McGregor C G. Systematic evaluation of distribution of transgene expression after adenovirus-mediated gene transfer to the transplanted heart [In Process Citation].  Transpl Int. 1998;  11 (5) 373-377
• 19 Wang J, Ma Y, Knechtle S J. Adenovirus-mediated gene transfer into rat cardiac allografts. Comparison of direct injection and perfusion.  Transplantation. 1996;  61 (12) 1726-1729
• 20 Barr E, Carroll J, Kalynych A M. et al . Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus.  Gene Ther. 1994;  1 (1) 51-58
• 21 Mülhauser J, Johnes M, Yamada I. et al . Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors.  Gene Therapy. 1996;  3 145-153
• 22 Baker J E, Boerboom L E, Olinger G N. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.  Journal of Thoracic & Cardiovascular Surgery. 1988;  96 (5) 717-724
• 23 Bove E L, Stammers A H. Recovery of left ventricular function after hypothermic global ischemia. Age-related differences in the isolated working rabbit heart.  Journal of Thoracic & Cardiovascular Surgery. 1986;  91 (1) 115-122
• 24 Asfour B, Hare J M, Kohl T. et al . A simple new model of physiologically working heterotopic rat heart transplantation provides hemodynamic performance equivalent to that of an orthotopic heart.  J Heart Lung Transplant. 1999;  18 (10) 927-936
• 25 Feeley B T, Poston R S, Park A K. et al . Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts.  Transplantation. 2000;  69 (6) 1067-1074